Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer
Alberto Chiappori, George Simon, Charles Williams, Eric Haura, Caio Rocha-Lima, Henry Wagner, Gerold Bepler, Scott Antonia
Dive into the research topics of 'Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.